ARIX Arix Bioscience

Director/PDMR Shareholding

Arix Bioscience PLC (ARIX)
Director/PDMR Shareholding

16-Aug-2021 / 07:00 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.

Arix Bioscience plc

Director/PDMR Shareholding

 

 

Arix Bioscience plc (the "Company") today announces the annual award of nil cost options to Interim CEO Robert Lyne, which are subject to performance conditions over a three-year assessment period, in accordance with the Company's Remuneration Policy.

 

PDMR DEALING NOTIFICATION

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Robert Lyne

2

Reason for the notification

a)

Position / status

Interim Chief Executive Officer

b)

Initial notification /

Amendment

Initial Notification

3

Details of issuer

a)

Name

Arix Bioscience plc

b)

LEI

213800OVT3AHQCXNIX43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of Arix Bioscience plc

Identification code

GB00BD045071

b)

Nature of the transaction

Award of nil-cost options under the Arix Bioscience plc Executive Incentive Plan ("EIP") 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

352,335

d)

Aggregated information

Aggregated price

Aggregated volume

N/A (single transaction)

N/A (single transaction)

e)

Date of the transaction

13 August 2021

f)

Place of the transaction

Outside a trading venue

 

 

 

 

For further information please contact:

 

Optimum Strategic Communications

Mary Clark, Manel Mateus

+44 (0)20 8078 4357

 

 - Ends -
ISIN: GB00BD045071
Category Code: DSH
TIDM: ARIX
LEI Code: 213800OVT3AHQCXNIX43
OAM Categories: 2.3. Major shareholding notifications
Sequence No.: 119950
EQS News ID: 1226354

 
End of Announcement EQS News Service

fncls.ssp?fn=show_t_gif&application_id=1226354&application_name=news&site_id=research_pool
EN
16/08/2021

Underlying

ARIXArix Bioscience

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Arix Bioscience

ECK ECKOH
TYM Tertiary Minera... ... (+9)

Hybridan Small Cap Feast - 12 Feb 24

12th February 2024 @HybridanLLP Status of this Note and Disclaimer This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment obj...

ECK ECKOH
TYM TERTIARY MINERALS PLC
GOOD GOOD ENERGY GROUP
VAL VALIRX
DCTA DIRECTA PLUS
ARIX ARIX BIOSCIENCE
JNEO JOURNEO PLC
POLB POOLBEG PHARMA PLC
ECR ECR MINERALS PLC
02/12/24 February 12, 2024 1 EN
 PRESS RELEASE
Free
ARIX ARIX BIOSCIENCE

Scheme Effective

Arix Bioscience PLC (ARIX) Scheme Effective 12-Feb-2024 / 12:00 GMT/BST THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM, THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA), AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. FOR IMMEDIATE RELEASE Legal En...

February 12, 2024 1 EN
 PRESS RELEASE
Free
ARIX ARIX BIOSCIENCE

Suspension of Trading in Shares

Arix Bioscience PLC (ARIX) Suspension of Trading in Shares 12-Feb-2024 / 07:00 GMT/BST THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM, THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA), AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. FOR IMMEDIATE RE...

February 12, 2024 1 EN
 PRESS RELEASE
Free
ARIX ARIX BIOSCIENCE

Transaction Update

Arix Bioscience PLC (ARIX) Transaction Update 07-Feb-2024 / 11:30 GMT/BST THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM, THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA), AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. FOR IMMEDIATE RELEASE Legal ...

February 7, 2024 1 EN
 PRESS RELEASE
Free
ARIX ARIX BIOSCIENCE

Results of First General Meeting

Arix Bioscience PLC (ARIX) Results of First General Meeting 29-Jan-2024 / 12:15 GMT/BST THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM, THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA), AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. FOR IMMEDIATE R...

January 29, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch